MENU
+Compare
ONC
Stock ticker: NASDAQ
AS OF
Dec 3, 04:59 PM (EDT)
Price
$338.00
Change
+$7.82 (+2.37%)
Capitalization
39.29B

ONC BeOne Medicines Ltd Forecast, Technical & Fundamental Analysis

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales... Show more

Industry: #Biotechnology
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ONC with price predictions
Nov 28, 2025

ONC's Stochastic Oscillator remains in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ONC moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ONC crossed bullishly above the 50-day moving average on November 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 228 cases where ONC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ONC moved out of overbought territory on November 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ONC as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ONC turned negative on November 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ONC broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.993) is normal, around the industry mean (27.312). ONC's P/E Ratio (645.865) is considerably higher than the industry average of (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (7.513) is also within normal values, averaging (321.020).

View a ticker or compare two or three
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ONC is expected to report earnings to fall 46.79% to $1.41 per share on April 01

BeOne Medicines Ltd ONC Stock Earnings Reports
Q4'25
Est.
$1.41
Q3'25
Beat
by $1.85
Q2'25
Missed
by $0.04
Q1'25
Beat
by $1.65
Q4'24
Missed
by $0.42
The last earnings report on November 06 showed earnings per share of $2.65, beating the estimate of 80 cents. With 55.19K shares outstanding, the current market capitalization sits at 39.29B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FFLG30.000.15
+0.50%
Fidelity Fundamental Large Cap Gr ETF
DIHP31.170.08
+0.24%
Dimensional International High Pbly ETF
ESG156.690.18
+0.12%
FlexShares STOXX US ESG Select ETF
GGM27.35N/A
N/A
GGM Macro Alignment ETF
YGLD43.00-0.42
-0.97%
Simplify Gold Strategy PLUS Income ETF

ONC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
-1.73%
ZLAB - ONC
55%
Loosely correlated
-1.86%
MDGL - ONC
42%
Loosely correlated
-1.10%
WXXWY - ONC
37%
Loosely correlated
N/A
AXON - ONC
37%
Loosely correlated
+0.91%
GOSS - ONC
35%
Loosely correlated
-5.10%
More